Geneoscopy
Healthcare & Life Sciences
Recent Finacing
Series C
Recent Raise
$105M
Geneoscopy, Inc. develops and commercializes RNA-based diagnostic tests for colorectal cancer and inflammatory bowel disease.
Focus Areas
Life sciences
Colorectal cancer
Non-invasive screening
Diagnostic tests
RNA-based platform
Gastrointestinal health
Investors
